ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 97 out of 1024

$936K Total Retail Price of All Prescriptions

Rank: 69 out of 1024

358 Patients Receiving at Least One Drug in Part D
79% Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

16% of this provider’s 358 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 358 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 588 510 89 1 3
METOPROLOL SUCCINATE 374 332 49 2 12
ATORVASTATIN CALCIUM 366 325 58 3 1
LEVOTHYROXINE SODIUM 314 276 48 4 2
METFORMIN HCL 279 212 45 5 10
BENICAR 275 270* 37 6 83
FUROSEMIDE 245 224 53 7 6
METOPROLOL TARTRATE 236 216 37 8 7
LISINOPRIL 227 203 40 9 4
NEXIUM 220 179 43 10 33
OXYCODONE HCL 215 77 40 S2 11 55
CLOPIDOGREL 207 202* 33 12 28
SIMVASTATIN 203 154 36 13 5
ZOLPIDEM TARTRATE 190 177 33 14 19
DIOVAN 171 143 23 15 21
OMEPRAZOLE 167 136 29 16 9
PRAVASTATIN SODIUM 150 135 21 17 15
CRESTOR 148 148 29 18 20
PANTOPRAZOLE SODIUM 141 112 28 19 29
ALPRAZOLAM 137 80 25 B 20 17
HYDROCHLOROTHIAZIDE 128 100 21 21 11
AVODART 119 114* 18 22 176
TAMSULOSIN HCL 117 112* 24 23 24
ZETIA 115 115 14 24 52
DILTIAZEM 24HR ER 112 107* 14 25 108
GABAPENTIN 112 92 25 25 18
ESCITALOPRAM OXALATE 105 86 20 27 14
SPIRIVA 98 93* 17 28 47
LORAZEPAM 96 62 23 B 29 26
BENICAR HCT 95 90* 13 30 112
LEVOFLOXACIN 90 79 63 31 94
WARFARIN SODIUM 90 75 16 31 8
DONEPEZIL HCL 88 88 13 33 25
SERTRALINE HCL 85 80* 20 34 23
LIDODERM 84 79* 34 35 69
ISOSORBIDE MONONITRATE ER 82 82 14 36 63
LOSARTAN POTASSIUM 81 69 12 37 16
VOLTAREN 80 75* 28 38 164
ATENOLOL 80 65 12 38 13
ADVAIR DISKUS 78 73* 16 40 41
ENALAPRIL MALEATE 78 <11 <11 40 89
TRAZODONE HCL 76 58 22 42 22
OXYCONTIN 74 <11 <11 S2 43 102
LOVAZA 68 63* 13 44 130
ALENDRONATE SODIUM 65 54 13 45 39
JANUVIA 64 59* 12 46 45
CITALOPRAM HBR 62 50 16 47 37
DIAZEPAM 61 35 20 B 48 117
SYNTHROID 60 55* 11 49 43
PREDNISONE 58 41 24 50 38
POTASSIUM CHLORIDE 58 41 12 50 30
CYMBALTA 56 51* 14 52 35
NAMENDA 55 <11 <11 53 27
GLYBURIDE 54 49* 11 R 54 84
DEXILANT 54 <11 <11 54 113
CARVEDILOL 54 54 11 54 40
FENTANYL 54 <11 <11 S2 54 99
HYDROCODONE-ACETAMINOPHEN 53 48* 15 S3 58 32
ALLOPURINOL 50 <11 <11 59 34
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.